Offer - Urjas Oil for just ₹ 1 X
Clobetasol + Ofloxacin + Ornidazole + Terbinafine is an allopathic medicine The correct dosage of Clobetasol + Ofloxacin + Ornidazole + Terbinafine depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Clobetasol + Ofloxacin + Ornidazole + Terbinafine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Clobetasol + Ofloxacin + Ornidazole + Terbinafine is used -
Common
Is the use of Clobetasol + Ofloxacin + Ornidazole + Terbinafine safe for pregnant women?
It is not known what effect Clobetasol + Ofloxacin + Ornidazole + Terbinafine will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Clobetasol + Ofloxacin + Ornidazole + Terbinafine safe during breastfeeding?
There is no research available on the side effects of Clobetasol + Ofloxacin + Ornidazole + Terbinafine in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Clobetasol + Ofloxacin + Ornidazole + Terbinafine on the Kidneys?
There are no side effects of Clobetasol + Ofloxacin + Ornidazole + Terbinafine on the kidneys.
What is the effect of Clobetasol + Ofloxacin + Ornidazole + Terbinafine on the Liver?
There are no any side effects of Clobetasol + Ofloxacin + Ornidazole + Terbinafine on the liver.
What is the effect of Clobetasol + Ofloxacin + Ornidazole + Terbinafine on the Heart?
You can take Clobetasol + Ofloxacin + Ornidazole + Terbinafine without any fear of damage to the heart.
Clobetasol + Ofloxacin + Ornidazole + Terbinafine should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clobetasol + Ofloxacin + Ornidazole + Terbinafine unless your doctor advises you to do so -
Is this Clobetasol + Ofloxacin + Ornidazole + Terbinafine habit forming or addictive?
No, you will not get addicted to Clobetasol + Ofloxacin + Ornidazole + Terbinafine .
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Clobetasol + Ofloxacin + Ornidazole + Terbinafine since it will not make you feel sleepy.
Is it safe?
Clobetasol + Ofloxacin + Ornidazole + Terbinafine is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Clobetasol + Ofloxacin + Ornidazole + Terbinafine in mental disorders is not effective.
Interaction between Food and Clobetasol + Ofloxacin + Ornidazole + Terbinafine
Due to a lack of research, nothing can be said about the consequences of taking Clobetasol + Ofloxacin + Ornidazole + Terbinafine together with food.
Interaction between Alcohol and Clobetasol + Ofloxacin + Ornidazole + Terbinafine
No research has been done on this till date. Therefore, it is not known what the effect of taking Clobetasol + Ofloxacin + Ornidazole + Terbinafine with alcohol will be.
Yes, Clobetasol + Ofloxacin + Ornidazole + Terbinafine might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the Clobetasol + Ofloxacin + Ornidazole + Terbinafine can be absorbed by the skin.
Application of Clobetasol + Ofloxacin + Ornidazole + Terbinafine on the face must be avoided but if it has been advised by your doctor then you can use it only for a short-term period not more than 5 days because the skin on your face thins easily.
Clobetasol + Ofloxacin + Ornidazole + Terbinafine is used for the short-term treatment up to 2 weeks and if required then maximum up to 4 weeks. You are advised to use it as directed by your doctor. Do not use this medicine longer than prescribed by your doctor to avoid the unpleasant side effect.
Clobetasol + Ofloxacin + Ornidazole + Terbinafine contains clobetasol which is presumed to work by promoting the induction of inhibitory proteins (lipocortins) in the body. Lipocortins prevents the release of arachidonic acid which causes synthesis and release of certain chemicals such as histamine, leukotrienes, and prostaglandins that causes inflammation. In this way Clobetasol + Ofloxacin + Ornidazole + Terbinafine prevents the skin inflammation which provides relief to the patient from rash, itching, and redness.
No, Clobetasol + Ofloxacin + Ornidazole + Terbinafine does not cause yeast infections. It has not been reported by the patients who are taking this drug.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamisil (terbinafine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 795-796
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
SmPC [Internet]: Dermovate Cream (clobetasol propionate). GlaxoSmithKline UK
Description and Brand Names [Internet]: Drugs and Supplements Terbinafine (Topical Route). IBM Micromedex